Cyclerion Therapeutics Balance Sheet (2019-2025) | CYCN

Balance Sheet Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Assets
Current Assets
Cash & Equivalents 141.03M117.03M94.89M67.10M56.46M66.84M54.40M41.43M70.39M62.50M53.96M41.12M30.32M20.41M13.38M7.17M5.64M9.11M7.57M5.70M4.59M2.87M3.23M3.64M3.01M4.57M
Cash & Current Investments 141.03M117.03M94.89M67.10M56.46M66.84M54.40M41.43M70.39M62.50M53.96M41.12M30.32M20.41M13.38M7.17M5.64M9.11M7.57M5.70M4.59M2.87M3.23M3.64M3.01M4.57M
Receivables - Net 0.16M0.10M0.23M0.23M0.23M0.10M0.10M0.04M0.56M0.58M0.53M0.10M
Receivables - Other 1.86M1.44M1.47M1.03M0.75M0.40M0.13M
Receivables 0.13M0.16M0.10M0.23M0.23M0.23M0.10M0.10M0.04M0.56M0.58M0.53M0.10M
Prepaid Assets 0.93M1.78M2.16M2.86M1.87M2.26M1.67M3.16M1.80M1.83M0.56M0.93M1.01M0.65M0.54M0.81M0.57M1.04M0.73M0.44M0.31M0.12M0.62M0.42M0.26M0.46M0.39M
Current Assets 0.94M144.69M120.71M101.20M70.13M59.56M70.12M58.50M44.45M72.99M63.68M55.46M42.84M31.68M21.66M14.82M8.34M7.11M9.86M8.02M6.01M4.71M3.55M4.22M4.50M4.02M5.07M
Non-Current Assets
Property, Plant & Equipment (Net) 8.81M12.75M12.11M11.61M11.60M10.79M10.18M6.87M0.07M0.15M0.11M0.07M0.02M
Long-Term Investments 5.35M5.35M5.35M5.35M5.35M5.35M5.35M5.35M5.35M
Other Non-Current Assets 0.02M7.73M7.73M4.99M4.99M4.99M3.84M3.84M3.84M2.59M2.50M2.41M2.32M2.22M2.13M2.04M1.95M1.86M
Non-Current Assets 8.83M90.81M89.00M85.28M69.90M68.48M61.28M56.88M55.52M2.74M4.06M3.87M3.69M3.53M3.40M3.26M3.12M2.98M5.35M5.35M5.35M5.35M5.35M5.35M5.35M5.35M5.35M
Assets 9.77M235.50M209.70M186.48M140.03M128.04M131.40M115.38M99.97M75.73M67.74M59.33M46.52M35.21M25.05M18.08M11.46M10.10M15.21M13.37M11.36M10.06M8.90M9.57M9.85M9.37M10.41M
Liabilities
Current Liabilities
Accounts Payables 5.67M6.86M4.82M3.23M1.46M2.21M1.36M1.15M1.09M1.39M1.17M1.83M2.52M2.77M1.65M2.97M3.92M1.86M0.81M1.20M0.74M0.65M0.30M0.39M0.48M0.46M0.48M
Notes Payables 3.51M3.51M3.51M3.51M3.51M3.51M
Payables 5.67M6.86M4.82M3.23M1.46M5.72M4.87M4.66M4.60M4.89M4.68M1.83M2.52M2.77M1.65M2.97M3.92M1.86M0.81M1.20M0.74M0.65M0.30M0.39M0.48M0.46M0.48M
Accumulated Expenses 6.24M7.02M7.30M9.32M4.56M5.11M5.61M7.29M3.86M3.38M3.43M6.35M4.54M4.76M4.32M2.38M2.00M2.46M1.17M0.80M0.61M0.53M0.32M0.28M0.53M0.27M0.35M
Other Accumulated Expenses 5.56M
Current Leases 0.87M3.25M3.42M2.67M2.79M3.13M3.29M1.40M
Total Current Liabilities 17.47M21.92M19.10M18.25M11.44M15.64M16.26M16.95M13.47M10.51M11.36M11.09M9.49M9.85M8.53M7.63M7.53M4.95M2.34M2.09M1.44M1.28M0.70M0.72M1.07M0.80M0.88M
Non-Current Liabilities
Operating Leases 72.40M71.41M70.50M47.05M46.29M39.79M38.93M38.07M
Other Non-Current Liabilities 0.05M
Total Non-Current Liabilities 17.47M
Total Liabilities 17.52M94.31M90.51M88.75M58.49M61.94M56.05M55.88M51.53M10.51M11.36M11.09M9.49M9.85M8.53M7.63M7.53M4.95M2.34M2.09M1.44M1.28M0.70M0.72M1.07M0.80M0.88M
Shareholder's Equity
Common Equity -7.75M141.19M119.20M97.73M81.54M66.10M75.35M59.49M48.43M65.22M56.39M48.25M37.03M25.36M16.52M10.45M3.92M5.15M12.87M11.29M9.92M8.78M8.20M8.85M8.78M8.57M9.54M
Shareholder's Equity -7.75M141.19M119.20M97.73M81.54M66.10M75.35M59.49M48.43M65.22M56.39M48.25M37.03M25.36M16.52M10.45M3.92M5.15M12.87M11.29M9.92M8.78M8.20M8.85M8.78M8.57M9.54M
Liabilities and Shareholders Equity 9.77M235.50M209.70M186.48M140.03M128.04M131.40M115.38M99.97M75.73M67.74M59.33M46.52M35.21M25.05M18.08M11.46M10.10M15.21M13.37M11.36M10.06M8.90M9.57M9.85M9.37M10.41M
Retained Earnings -32.25M-59.57M-85.63M-105.86M-125.39M-144.20M-163.43M-176.83M-193.01M-204.30M-215.08M-228.05M-241.44M-251.94M-259.15M-266.11M-270.29M-262.72M-264.42M-265.96M-267.30M-268.02M-267.49M-268.92M-269.25M-270.22M
Treasury Shares 0.88M0.89M0.73M0.29M0.05M0.13M0.15M0.09M0.05M0.04M0.04M0.81M0.03M0.17M0.21M0.19M0.18M0.16M0.15M0.13M0.12M